CMCSA
49
-3
C
64
3
MMC
65
3
PLD
61
5
HSY
38
3
BMY
58
-2
F
60
2
DUK
57
2
QCOM
52
3
RRC
58
-2
WAT
57
2
GME
70
4
TDC
83
3
HAS
37
4
EQT
54
-3
VRSK
80
3
FOXA
52
-7
NWSA
65
2
VFC
57
4
GOOG
55
5
CMCSA
49
-3
C
64
3
MMC
65
3
PLD
61
5
HSY
38
3
BMY
58
-2
F
60
2
DUK
57
2
QCOM
52
3
RRC
58
-2
WAT
57
2
GME
70
4
TDC
83
3
HAS
37
4
EQT
54
-3
VRSK
80
3
FOXA
52
-7
NWSA
65
2
VFC
57
4
GOOG
55
5
Financhill
Back

United Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54

UTHR
United Therapeutics

Last Price:
377.01
Seasonality Move:
10.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

United Therapeutics Price Quote

$377.01
+8.35 (+2.27%)
(Updated: November 26, 2024 at 5:55 PM ET)

United Therapeutics Key Stats

Buy
54
United Therapeutics (UTHR) is a Buy
Day range:
$368.18 - $376.98
52-week range:
$208.62 - $417.82
Dividend yield:
0%
P/E ratio:
18.61
P/S ratio:
6.54
P/B ratio:
2.7%
Volume:
509.1K
Avg. volume:
371.1K
1-year change:
59.5%
Market cap:
$16.5B
Revenue:
$2.3B
EPS:
$22.77

How Much Does United Therapeutics Make?

Is United Therapeutics Growing As A Company?

  • What Is United Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is United Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.19%

United Therapeutics Stock Price Performance

What Is United Therapeutics 52-Week High & Low?

United Therapeutics Price To Free Cash Flow

Is It Risky To Buy United Therapeutics?

Is United Therapeutics Cash Flow Positive?

  • What Is UTHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.1B
  • What Is United Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is United Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $582.5M

United Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    UTHR return on invested capital is 17.45%
  • What Is United Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 16.09%
  • What Is UTHR Return On Equity?
    ROE is a measure of profitability and is 19.26%

United Therapeutics Earnings Date & Stock Price

United Therapeutics Competitors

United Therapeutics Dividend Yield

United Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 18.77% -2.19%
Revenue: 22.89% 3.61%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 6
Sell Recommendations: 1
Price Target: 382.22
Upside from Last Price: 3.68%

Major Shareholders

  • How many UTHR shares are owned by institutional investors?
    79.9M UTHR shares are owned by institutional investors
  • How many UTHR shares are owned by insiders?
    125.5K UTHR shares are owned by insiders